Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Autistic People in Dental and Medical Clinics : Challenges and Solutions / / by Gabriel Bennett
| Autistic People in Dental and Medical Clinics : Challenges and Solutions / / by Gabriel Bennett |
| Autore | Bennett Gabriel |
| Edizione | [1st ed. 2023.] |
| Pubbl/distr/stampa | Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 |
| Descrizione fisica | 1 online resource (166 pages) |
| Disciplina | 362.11087 |
| Collana | New Perspectives in Behavioral & Health Sciences |
| Soggetto topico |
Psychology
Medical sciences Public health Medical policy Behavioral Sciences and Psychology Health Sciences Public Health Health Policy Autisme Relacions metge-pacient |
| Soggetto genere / forma | Llibres electrònics |
| Soggetto non controllato |
Public Health
Medical |
| ISBN |
9789819923595
9789819923588 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | Chapter1. Introduction -- Chapter2. Autistics in medical settings -- Chapter3. Autistics in dental clinics -- Chapter5. Final comments. |
| Record Nr. | UNINA-9910728400503321 |
Bennett Gabriel
|
||
| Singapore : , : Springer Nature Singapore : , : Imprint : Springer, , 2023 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
The Role That Assistance Dogs Play in Supporting People with Disabilities
| The Role That Assistance Dogs Play in Supporting People with Disabilities |
| Autore | Bennett Gabriel |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Singapore : , : Springer, , 2024 |
| Descrizione fisica | 1 online resource (100 pages) |
| Altri autori (Persone) | GoodallEmma |
| Collana | SpringerBriefs in Modern Perspectives on Disability Research Series |
| ISBN | 981-9714-92-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Statement About the Usage of Artificial Intelligence -- Contents -- About the Authors -- Acronyms -- List of Figures -- List of Tables -- 1 Introduction -- 1.1 An Introduction to Dogs Assisting People with Disabilities -- 1.2 Relevance of This Book to the Modern Perspectives on Disability Research SpringerBrief Series -- 1.3 Research Questions -- 1.4 Search Procedures for Relevant Citations -- 1.5 Methodological Strengths and Weaknesses of This Study -- 1.5.1 Methodological Strengths -- 1.5.2 Methodological Weaknesses -- 1.6 Intended Audience for This Book -- 1.7 Benefits of This Book -- 1.8 Description of Upcoming Chapters -- 1.8.1 Chapter 2-Results in the Existing Literature -- 1.8.2 Chapter 3-Limitations of Current Studies -- 1.8.3 Chapter 4-Directions for Research in the Future -- References -- 2 Results in the Existing Literature -- 2.1 Consequences of Owning an Assistance or Service Dog -- 2.1.1 Veterans and Ex-military Service People -- 2.1.2 Family Members of Veterans -- 2.1.3 Elderly -- 2.1.4 People with Disabilities -- 2.1.5 People with Dementia -- 2.1.6 People with Mental Health Disorders -- 2.1.7 Autistic Children -- 2.2 Documented Experiences About Parents Using an Assistance or Service Dog for Their Children -- 2.3 Views of Professionals About the Usage of Assistance or Service Dogs -- 2.4 Conclusion -- References -- 3 Limitations of Current Studies -- 3.1 Limitations in the Reviewed Literature About Assistance or Service Dogs -- 3.1.1 Military Veterans -- 3.1.2 Family Members of Veterans -- 3.1.3 Elderly -- 3.1.4 People with Disabilities -- 3.1.5 People with Dementia -- 3.1.6 People with Mental Health Disorders -- 3.1.7 Autistic Children -- 3.1.8 Parents of Children with a Disability -- 3.1.9 Views of Professionals About the Usage of Assistance or Service Dogs -- 3.2 Conclusion -- References.
4 Directions for Research in the Future -- 4.1 Small Sample Size -- 4.2 Self-Reporting by Participants -- 4.3 Recruiting from a Single Provider -- 4.4 Missing Data -- 4.5 Limited Diversity Within the Sample -- 4.6 Inconsistent Exposure Time to Dogs -- 4.7 Exploring the Holistic Benefits of Assistance or Service Dogs -- 4.8 Conducting Follow-Up Examinations -- 4.9 Closing Remarks -- References -- Appendix Dataset. |
| Record Nr. | UNINA-9910861091603321 |
|
Bennett Gabriel
|
||
| Singapore : , : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Senotherapy : A Potential Pharmacological Strategy for Prolonging Human Lifespan and Healthspan
| Senotherapy : A Potential Pharmacological Strategy for Prolonging Human Lifespan and Healthspan |
| Autore | Bennett Gabriel |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Singapore : , : Springer, , 2024 |
| Descrizione fisica | 1 online resource (113 pages) |
| Collana | SpringerBriefs in Modern Perspectives on Disability Research Series |
| ISBN |
9789819736379
9789819736362 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Intro -- Statement About the Usage of Artificial Intelligence -- Contents -- About the Author -- Abbreviations -- List of Figures -- Chapter 1: Introduction to Senotherapies -- 1.1 Hallmarks of Biological Ageing -- 1.2 Senescent Cells and Age-Associated Diseases -- 1.2.1 Senescent Cell Accumulation -- 1.2.2 Increased Amounts of SASPs Contribute to Senescent Cell Development -- 1.3 Senotherapeutics: Treating Senescent Cells -- 1.3.1 An Introduction to Senotherapeutics -- 1.3.2 Senolytics -- 1.3.3 Senomorphics -- 1.4 Relevance of This Book to the Modern Perspectives on Disability Research SpringerBrief Series -- 1.5 Intended Audience of This Book -- 1.6 Pedagogical Features of This Book -- 1.7 Description of Upcoming Chapters -- 1.7.1 Chapter 2: The Accumulation of Senescent Cells and Disease -- 1.7.2 Chapter 3: Current Research About Senotherapeutics -- 1.7.3 Chapter 4: Final Comments -- Further Reading -- References -- Chapter 2: The Accumulation of Senescent Cells and Diseases -- 2.1 Causational Relationship Between Senescent Cell Accumulation and Age-Associated Diseases -- 2.1.1 Type 2 Diabetes -- 2.1.2 Type 1 Diabetes -- 2.1.3 Idiopathic Pulmonary Fibrosis (IPF) -- 2.1.4 Viral Infections -- 2.1.5 Ophthalmic Diseases -- 2.1.6 Multiple Sclerosis -- 2.1.7 Parkinson's Disease -- 2.1.8 Obesity-Related Diseases -- 2.1.9 Non-alcoholic Fatty Liver Disease (NAFLD) -- 2.1.10 Non-alcoholic Steatohepatitis (NASH) -- 2.1.11 Periodontitis -- 2.2 Conclusion -- Further Reading -- References -- Chapter 3: Current Research About Senotherapeutics -- 3.1 Senolytic Potential of Dasatinib and Quercetin (D + Q) -- 3.1.1 Learning and Memory -- 3.1.2 Reduced Adipose Tissue Inflammation and Improved Systemic Metabolic Function -- 3.1.3 Muscle Wasting in Chronic Kidney Disease (CKD) -- 3.1.4 Age-Dependent Intervertebral Disc Degeneration.
3.1.5 Non-alcoholic Fatty Liver Disease (NAFLD) -- 3.1.6 Cardiovascular Diseases -- 3.1.7 Obesity-Induced Metabolic Disorders -- 3.2 Senomorphic Potential of Metformin -- 3.3 Senomorphic Potential of Rapamycin -- 3.4 Human Trials of Senotherapeutic Candidates -- 3.5 Future Opportunities for Senotherapeutic Research -- 3.5.1 Evaluating the Toxicity of Senotherapeutics -- 3.5.2 Defining and Classifying Ageing as a Disease -- 3.5.3 Performing More Studies About Treatment Regimen and Frequency -- 3.5.4 Combining Senotherapies with Other Anti-Ageing Treatments -- 3.5.5 Addressing the Heterogeneity of Senescent Cells -- 3.5.6 Validating if Senotherapies Slow Ageing -- 3.5.7 Preventing Senotherapies from Inhibiting the Therapeutic Benefits of Senescent Cells -- 3.5.8 Examining the Long-Term Therapeutic Benefits of Senotherapies -- 3.5.9 Conducting More Research About Senotherapeutics -- 3.6 Conclusion -- Further Reading -- References -- Chapter 4: Final Comments -- References -- Appendices -- Appendix 1: History of the Discovery and Development of Metformin to Treat Diabetes -- Appendix 2: Summary of Key Targets and Pathways Impacted by Metformin as Evidenced by Their Modulation in Cell Lines, C. elegans, Drosophila, and Rodents -- Appendix 3: Clinical Trials Using Metformin for Targeting Biological Ageing on https://www.clinicaltrials.gov as of February 18, 2024 -- Appendix 4: Characteristics of Studies Examining the Effects of Rapamycin and Its Derivatives on Healthy Individuals and Individuals with Age-Related Diseases -- Appendix 5: Clinical Trials of Senotherapeutics Registered on https://www.clinicaltrials.gov as of February 18, 2024 -- Glossary -- References. |
| Record Nr. | UNINA-9910872198803321 |
|
Bennett Gabriel
|
||
| Singapore : , : Springer, , 2024 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||